5366 results
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
) in HFrEF and CKD ... Therapy #GDMT #CKD ... #HFrEF #management ... #pharmacology #cardiology
Definitions of AKI, CKD, AKD
Acute Kidney Injury (AKI):
 • Increase in SCr by 2 50% within
Definitions of AKI, CKD ... , AKD Acute Kidney ... Kidney Disease (CKD ... /CKD • No structural ... damage #AKI #CKD
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD EMPA-REG ... SGLT2i in HF and CKD ... SGLT2i in HF and CKD ... kidney events in CKD ... patients with CKD
Gout Management in CKD
 • Colchicine
 • NSAID
 • Glucocorticoid
 • ACTH
 • Interleukin-1 Inhibitors

#Gout #Management
Gout Management ... in CKD • Colchicine ... Inhibitors #Gout #Management ... #CKD #rheumatology
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
Type 2 Medication Management ... Established ASCVD or CKD ... established ASCVD or CKD ... Type2 #Medication #Management
Resistant Hypertension in CKD - Diagnosis and Management Algorithm

#Resistant #Hypertension #CKD #Diagnosis #Management #Algorithm
Hypertension in CKD ... Diagnosis and Management ... #Hypertension #CKD ... #Diagnosis #Management
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Dissection • CKD ... , DM, ESRD, PKD ... pharmacology #table #management
A primer on the causes, evaluation and management of Acute Myocardial Infarction in Young Patients. 
Obstructive:
evaluation and management ... • Atheromatous CAD ... Non-atheromatous CAD ... Hypercoagulable States #cardiology ... MyocardialInfarction #Young #cardiology
Contraception and CKD
Preferred Contraception in kidney disease: Intrauterine devices and progesterone only methods
Avoid combined progesterone/estrogen pills

#Contraception
Contraception and CKD ... Contraception #CKD ... #management #treatment
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
metformin in T2D and CKD ... cardiovascular disease: CKD ... , #KDIGO2020 #CKD ... #Diabetes Management ... in CKD #management